Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Prognostic significance of clinicopathological parameters, margin width and locoregional recurrences on outcome of primary and radiation associated breast angiosarcoma- results from a large UK sarcoma regional service
Neither patient age nor angiosarcoma histological grade correlated with recurrences.
»
03/28/26
RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia
Varying degrees of MERTK expression in AML cell lines.
»
03/28/26
Clinical impact of novel cardiovascular and immune system dosimetric parameters in stage III NSCLC patients treated with radiotherapy
PTV only parameter significantly associated with EDIC.
»
03/28/26
Predictors of survival for locally advanced rectal cancer patients with poor response to neoadjuvant chemoradiotherapy
Surgical margin, ypN2 status, and number of dissected LNs remained independent predictors for DFS.
»
03/28/26
Hospital-based patterns of esophageal and gastric cancer cases at a major tertiary referral center in Kabul, Afghanistan: a retrospective case series
Highest proportion of cases occurred in 55–64-year age group.
»
03/29/26
[18F]FDG PET/CT multiomics identifies Hedgehog-driven HPV-negative head and neck squamous cell carcinoma
Validation of HH pathway inhibition in HPV-negative HNSCC.
»
03/29/26
RBM15 drives bladder cancer progression through YTHDF2-dependent m6A-mediated regulation of ZO2
METTL3 catalytic inhibitor STM2457 suppressed BC growth and lung metastasis.
»
03/30/26
Demographic and regional trends in Nonmelanoma skin cancer mortality in the United States, 1999-2020
U.S. Southern and rural areas bore the greatest burden, with persistent increases.
»
03/31/26
PREDICT v3.0 outperforms v2.2 in young (25-40 years) breast cancer patients according to real-world data from a large Swedish population-based registry
Discrimination excellent for predicting 5-year outcomes in both models.
»
03/31/26
Radionecrosis risk and local control after CyberKnife fractionated stereotactic radiotherapy for brain metastases: an eight-year single-centre cohort
FSRT achieved durable LC with acceptable rates of symptomatic RN.
»
03/31/26
< Prev
Next >